Cargando…
Drugs for Non-alcoholic Steatohepatitis (NASH): Quest for the Holy Grail
Nonalcoholic fatty liver disease (NAFLD) is a global epidemic that is likely to become the most common cause of chronic liver disease in the next decade, worldwide. Though numerous drugs have been evaluated in clinical trials, most of them have returned inconclusive results and shown poorly-tolerate...
| Autores principales: | , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
XIA & HE Publishing Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7868704/ https://www.ncbi.nlm.nih.gov/pubmed/33604254 http://dx.doi.org/10.14218/JCTH.2020.00055 |